AGM-260

N/A

Report date: 2024/11/13 15:02:24
NME

Base Information

Drug NameAGM-260
Drug Alias NameAGM-260
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionG-protein coupled receptor agonists
TargetsG-protein coupled receptor
Therapy Area/IndicationsColitis, Ulcerative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAnygen Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesAnygen Pharmaceuticals
Inactive CompaniesN/A
Active IndicationsColitis, Ulcerative
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A